Latest filing published 28 Oct 2015 for HAEMONETICS CORP, €14k.
Insider track record
No signal scores available.
Closed purchases
Based on 15 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -19.2%Entry US$38.81 · Close at T+365 US$31.34
- -3.0%Entry US$40.64 · Close at T+365 US$39.43
- +8.6%Entry US$35.72 · Close at T+365 US$38.81
- +40.2%Entry US$28.70 · Close at T+365 US$40.22
- +6.2%Entry US$33.63 · Close at T+365 US$35.72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Susan M. Hanlon: trading record in brief
Susan M. Hanlon discloses dealings in Haemonetics Corp to SEC (Form 4). Between 1 May 2006 and 26 October 2015, the trades on record add up to 78 filings.
The open-market side counts 16 purchases for €76k alongside 21 sales for €2.9M. Sales outweigh purchases by €2.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 9 share grants and 15 option exercises. 2015 to date brings no purchases and 5 sales.
The median purchase comes to €4,849. For 15 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 60% of cases, with a median move of +2.2%. These figures describe past trades and do not predict future prices.
On 28 October 2015 came the latest disclosure, an open-market sale for €14k in Haemonetics Corp. The last insider purchase was made public on 2 May 2013, 4,938 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Susan M. Hanlon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 497 shares@ US$32.13Common StockSEC:0001127602-15-029702:0
- 162 shares@ US$31.75Common StockSEC:0001127602-15-029610:0
- 6,000 shares@ US$27.50Common StockSEC:0000313143-15-000040:0
- 6,000 shares@ US$43.00Common StockSEC:0000313143-15-000040:1
- 4,000 shares@ US$26.47Common StockSEC:0000313143-15-000028:0
- 4,000 shares@ US$40.08Common StockSEC:0000313143-15-000028:1
- 7,000 shares@ US$26.47Common StockSEC:0000313143-15-000020:0
- 7,000 shares@ US$43.46Common StockSEC:0000313143-15-000020:1
- 144 shares@ US$35.92Common StockSEC:0000313143-14-000119:0
- 210 shares@ US$36.22Common StockSEC:0000313143-14-000119:1
- 186 shares@ US$36.22Common StockSEC:0000313143-14-000119:2
- 1,978 shares0Common StockSEC:0000313143-14-000113:0
- 157 shares@ US$35.44Common StockSEC:0000313143-14-000113:1
- 3,690 shares@ US$26.47Common StockSEC:0000313143-14-000025:0
- 3,690 shares@ US$39.00Common StockSEC:0000313143-14-000025:1
- 3,206 shares@ US$27.28Common StockSEC:0000313143-14-000019:0
- 3,206 shares@ US$38.37Common StockSEC:0000313143-14-000019:1
- 4,000 shares@ US$27.28Common StockSEC:0000313143-14-000002:0
- 4,000 shares@ US$41.80Common StockSEC:0000313143-14-000002:1
- 4,000 shares@ US$25.54Common StockSEC:0000313143-13-000199:0
- 4,000 shares@ US$43.50Common StockSEC:0000313143-13-000199:1
- 3,138 shares@ US$25.54Common StockSEC:0000313143-13-000198:0
- 3,138 shares@ US$43.07Common StockSEC:0000313143-13-000198:1
- 1,188 shares@ US$39.62Common StockSEC:0000313143-13-000195:0
- 149 shares@ US$41.09Common StockSEC:0000313143-13-000182:0
25 of 75 declarations
